Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study
Third-generation chimeric antigen receptor T cells (CARTs) for relapsed or refractory (r/r) chronic lymphocytic leukemia (CLL) may improve efficacy compared to second-generation CARTs due to their enhanced CAR design. We performed the first phase 1/2 investigator-initiated trial evaluating escalatin...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
27 August 2024
|
| In: |
Leukemia
Year: 2024, Volume: 38, Issue: 11, Pages: 2419-2428 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/s41375-024-02392-7 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1038/s41375-024-02392-7 Verlag, kostenfrei, Volltext: https://www.nature.com/articles/s41375-024-02392-7 |
| Author Notes: | Patrick Derigs, Maria-Luisa Schubert, Peter Dreger, Anita Schmitt, Schayan Yousefian, Simon Haas, Caroline Röthemeier, Brigitte Neuber, Angela Hückelhoven-Krauss, Monika Brüggemann, Helga Bernhard, Guido Kobbe, Albrecht Lindemann, Mathias Rummel, Birgit Michels, Felix Korell, Anthony D. Ho, Carsten Müller-Tidow and Michael Schmitt |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1935348787 | ||
| 003 | DE-627 | ||
| 005 | 20250905120449.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250905s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41375-024-02392-7 |2 doi | |
| 035 | |a (DE-627)1935348787 | ||
| 035 | |a (DE-599)KXP1935348787 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Derigs, Patrick |d 1991- |e VerfasserIn |0 (DE-588)1178057461 |0 (DE-627)1049128508 |0 (DE-576)517664216 |4 aut | |
| 245 | 1 | 0 | |a Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia |b a phase 1/2 study |c Patrick Derigs, Maria-Luisa Schubert, Peter Dreger, Anita Schmitt, Schayan Yousefian, Simon Haas, Caroline Röthemeier, Brigitte Neuber, Angela Hückelhoven-Krauss, Monika Brüggemann, Helga Bernhard, Guido Kobbe, Albrecht Lindemann, Mathias Rummel, Birgit Michels, Felix Korell, Anthony D. Ho, Carsten Müller-Tidow and Michael Schmitt |
| 246 | 3 | 0 | |a nineteen |
| 264 | 1 | |c 27 August 2024 | |
| 300 | |b Illustrationen | ||
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 05.09.2025 | ||
| 520 | |a Third-generation chimeric antigen receptor T cells (CARTs) for relapsed or refractory (r/r) chronic lymphocytic leukemia (CLL) may improve efficacy compared to second-generation CARTs due to their enhanced CAR design. We performed the first phase 1/2 investigator-initiated trial evaluating escalating doses of third-generation CARTs (HD-CAR-1) targeting CD19 in patients with r/r CLL and B-cell lymphoma. CLL eligibility criteria were failure to two therapy lines including at least one pathway inhibitor and/or allogeneic hematopoietic cell transplantation. Nine heavily pretreated patients received HD-CAR-1 at dose levels ranging from 1 × 106 to 200 × 106 CART/m2. In-house HD-CAR-1 manufacturing was successful for all patients. While neurotoxicity was absent, one case of grade 3 cytokine release syndrome was observed. By day 90, six patients (67%) attained a CR, five of these (83%) with undetectable MRD. With a median follow-up of 27 months, 2-year PFS and OS were 30% and 69%, respectively. HD-CAR-1 products of responders contained significantly more CD4 + T cells compared to non-responders. In non-responders, a strong enrichment of effector memory-like CD8 + T cells with high expression of CD39 and/or CD197 was observed. HD-CAR-1 demonstrated encouraging efficacy and exceptionally low treatment-specific toxicity, presenting new treatment options for patients with r/r CLL. Trial registration: #NCT03676504. | ||
| 650 | 4 | |a Chronic lymphocytic leukaemia | |
| 650 | 4 | |a Immunotherapy | |
| 650 | 4 | |a Phase I trials | |
| 650 | 4 | |a Phase II trials | |
| 650 | 4 | |a Translational research | |
| 700 | 1 | |a Schubert, Maria-Luisa |d 1982- |e VerfasserIn |0 (DE-588)1147867631 |0 (DE-627)1007273801 |0 (DE-576)49608089X |4 aut | |
| 700 | 1 | |a Dreger, Peter |e VerfasserIn |0 (DE-588)1028891881 |0 (DE-627)732699894 |0 (DE-576)376320966 |4 aut | |
| 700 | 1 | |a Schmitt, Anita |d 1969- |e VerfasserIn |0 (DE-588)141722495 |0 (DE-627)630587752 |0 (DE-576)325593892 |4 aut | |
| 700 | 1 | |a Yousefian, Schayan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haas, Simon |e VerfasserIn |4 aut | |
| 700 | 1 | |a Röthemeier, Caroline |e VerfasserIn |4 aut | |
| 700 | 1 | |a Neuber, Brigitte |d 1974- |e VerfasserIn |0 (DE-588)1052913563 |0 (DE-627)789293188 |0 (DE-576)408653884 |4 aut | |
| 700 | 1 | |a Hückelhoven-Krauss, Angela |d 1983- |e VerfasserIn |0 (DE-588)1034095889 |0 (DE-627)744057280 |0 (DE-576)381742822 |4 aut | |
| 700 | 1 | |a Brüggemann, Monika |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bernhard, Helga |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kobbe, Guido |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lindemann, Albrecht |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rummel, Mathias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Michels, Birgit |e VerfasserIn |4 aut | |
| 700 | 1 | |a Korell, Felix |e VerfasserIn |0 (DE-588)1214671659 |0 (DE-627)1725690284 |4 aut | |
| 700 | 1 | |a Ho, Anthony Dick |d 1948- |e VerfasserIn |0 (DE-588)108692477 |0 (DE-627)504904205 |0 (DE-576)19010466X |4 aut | |
| 700 | 1 | |a Müller-Tidow, Carsten |d 1968- |e VerfasserIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 aut | |
| 700 | 1 | |a Schmitt, Michael |d 1966- |e VerfasserIn |0 (DE-588)133177173 |0 (DE-627)538000600 |0 (DE-576)299672921 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1997 |g 38(2024), 11, Seite 2419-2428 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia a phase 1/2 study |
| 773 | 1 | 8 | |g volume:38 |g year:2024 |g number:11 |g pages:2419-2428 |g extent:10 |a Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia a phase 1/2 study |
| 856 | 4 | 0 | |u https://doi.org/10.1038/s41375-024-02392-7 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/s41375-024-02392-7 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250905 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 133177173 |a Schmitt, Michael |m 133177173:Schmitt, Michael |d 910000 |d 910100 |e 910000PS133177173 |e 910100PS133177173 |k 0/910000/ |k 1/910000/910100/ |p 19 |y j | ||
| 998 | |g 1015101798 |a Müller-Tidow, Carsten |m 1015101798:Müller-Tidow, Carsten |d 910000 |d 910100 |e 910000PM1015101798 |e 910100PM1015101798 |k 0/910000/ |k 1/910000/910100/ |p 18 | ||
| 998 | |g 108692477 |a Ho, Anthony Dick |m 108692477:Ho, Anthony Dick |d 910000 |d 910100 |e 910000PH108692477 |e 910100PH108692477 |k 0/910000/ |k 1/910000/910100/ |p 17 | ||
| 998 | |g 1214671659 |a Korell, Felix |m 1214671659:Korell, Felix |d 910000 |d 910100 |e 910000PK1214671659 |e 910100PK1214671659 |k 0/910000/ |k 1/910000/910100/ |p 16 | ||
| 998 | |g 1034095889 |a Hückelhoven-Krauss, Angela |m 1034095889:Hückelhoven-Krauss, Angela |d 910000 |d 910100 |e 910000PH1034095889 |e 910100PH1034095889 |k 0/910000/ |k 1/910000/910100/ |p 9 | ||
| 998 | |g 1052913563 |a Neuber, Brigitte |m 1052913563:Neuber, Brigitte |d 910000 |d 910100 |e 910000PN1052913563 |e 910100PN1052913563 |k 0/910000/ |k 1/910000/910100/ |p 8 | ||
| 998 | |g 141722495 |a Schmitt, Anita |m 141722495:Schmitt, Anita |d 910000 |d 910100 |d 50000 |e 910000PS141722495 |e 910100PS141722495 |e 50000PS141722495 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 4 | ||
| 998 | |g 1028891881 |a Dreger, Peter |m 1028891881:Dreger, Peter |d 910000 |d 910100 |e 910000PD1028891881 |e 910100PD1028891881 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 1147867631 |a Schubert, Maria-Luisa |m 1147867631:Schubert, Maria-Luisa |d 910000 |d 910100 |e 910000PS1147867631 |e 910100PS1147867631 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 1178057461 |a Derigs, Patrick |m 1178057461:Derigs, Patrick |d 910000 |d 910100 |e 910000PD1178057461 |e 910100PD1178057461 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1935348787 |e 4768924468 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"10 S.","noteIll":"Illustrationen"}],"title":[{"title":"Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia","subtitle":"a phase 1/2 study","title_sort":"Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia"}],"person":[{"given":"Patrick","roleDisplay":"VerfasserIn","family":"Derigs","role":"aut","display":"Derigs, Patrick"},{"roleDisplay":"VerfasserIn","given":"Maria-Luisa","family":"Schubert","role":"aut","display":"Schubert, Maria-Luisa"},{"family":"Dreger","given":"Peter","roleDisplay":"VerfasserIn","display":"Dreger, Peter","role":"aut"},{"family":"Schmitt","roleDisplay":"VerfasserIn","given":"Anita","display":"Schmitt, Anita","role":"aut"},{"role":"aut","display":"Yousefian, Schayan","given":"Schayan","roleDisplay":"VerfasserIn","family":"Yousefian"},{"family":"Haas","roleDisplay":"VerfasserIn","given":"Simon","display":"Haas, Simon","role":"aut"},{"family":"Röthemeier","given":"Caroline","roleDisplay":"VerfasserIn","display":"Röthemeier, Caroline","role":"aut"},{"roleDisplay":"VerfasserIn","given":"Brigitte","family":"Neuber","role":"aut","display":"Neuber, Brigitte"},{"role":"aut","display":"Hückelhoven-Krauss, Angela","given":"Angela","roleDisplay":"VerfasserIn","family":"Hückelhoven-Krauss"},{"display":"Brüggemann, Monika","role":"aut","family":"Brüggemann","roleDisplay":"VerfasserIn","given":"Monika"},{"family":"Bernhard","roleDisplay":"VerfasserIn","given":"Helga","display":"Bernhard, Helga","role":"aut"},{"family":"Kobbe","roleDisplay":"VerfasserIn","given":"Guido","display":"Kobbe, Guido","role":"aut"},{"role":"aut","display":"Lindemann, Albrecht","roleDisplay":"VerfasserIn","given":"Albrecht","family":"Lindemann"},{"family":"Rummel","given":"Mathias","roleDisplay":"VerfasserIn","display":"Rummel, Mathias","role":"aut"},{"display":"Michels, Birgit","role":"aut","family":"Michels","roleDisplay":"VerfasserIn","given":"Birgit"},{"role":"aut","display":"Korell, Felix","roleDisplay":"VerfasserIn","given":"Felix","family":"Korell"},{"family":"Ho","given":"Anthony Dick","roleDisplay":"VerfasserIn","display":"Ho, Anthony Dick","role":"aut"},{"role":"aut","display":"Müller-Tidow, Carsten","given":"Carsten","roleDisplay":"VerfasserIn","family":"Müller-Tidow"},{"display":"Schmitt, Michael","role":"aut","family":"Schmitt","roleDisplay":"VerfasserIn","given":"Michael"}],"name":{"displayForm":["Patrick Derigs, Maria-Luisa Schubert, Peter Dreger, Anita Schmitt, Schayan Yousefian, Simon Haas, Caroline Röthemeier, Brigitte Neuber, Angela Hückelhoven-Krauss, Monika Brüggemann, Helga Bernhard, Guido Kobbe, Albrecht Lindemann, Mathias Rummel, Birgit Michels, Felix Korell, Anthony D. Ho, Carsten Müller-Tidow and Michael Schmitt"]},"relHost":[{"origin":[{"publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedDisp":"1997-","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","dateIssuedKey":"1997"}],"disp":"Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia a phase 1/2 studyLeukemia","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"32046699X","note":["Gesehen am 15.03.04"],"pubHistory":["Nachgewiesen 11.1997 -"],"language":["eng"],"id":{"issn":["1476-5551"],"zdb":["2008023-2"],"eki":["32046699X"]},"part":{"text":"38(2024), 11, Seite 2419-2428","volume":"38","issue":"11","year":"2024","extent":"10","pages":"2419-2428"},"title":[{"subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia","title_sort":"Leukemia"}],"physDesc":[{"extent":"Online-Ressource"}]}],"id":{"eki":["1935348787"],"doi":["10.1038/s41375-024-02392-7"]},"language":["eng"],"note":["Gesehen am 05.09.2025"],"recId":"1935348787","type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"27 August 2024"}]} | ||
| SRT | |a DERIGSPATRTHIRDGENER2720 | ||